Norbornanes
Fencamfamin is a norbornane (bicyclo[2.2.1]heptane) stimulant introduced by Merck in the 1960s as Reactivan for fatigue. It acts as an indirect dopamine agonist, releasing dopamine and blocking its reuptake. It is a federal Schedule IV substance in the United States and a prohibited stimulant in sport. DiEt-Fencamfamin is the N,N-diethyl analogue, a compound with a PubChem record and no published pharmacology.
For the analogue, identity is the first problem. One vendor listing seen in November 2026 gives the diethyl compound's formula and CAS number, but the IUPAC name of fencamfamin itself, so a buyer cannot tell from the label which one they are being offered. An analogue of a Schedule IV drug is not covered by the Analogue Act, which reaches Schedule I and II, but fencamfamin itself is controlled.
No posts here yet.